Tested short TB meningitis treatment with stronger follow-up
Part of Brain & nervous system, Infections clinical trials.
This trial tests an intensified, shorter treatment plan for TB meningitis (TB in the lining around the brain) in adults, including people with HIV. It may help some patients get better with a structured plan while researchers compare treatment outcomes and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (over 18 years), with or without HIV
- Your doctors think you likely have TB meningitis (not another meningitis cause)
- You will sign consent and agree to an HIV test
- You live within 100 km of the study center and can come for supervised treatment
- You can follow the trial visits and follow-up schedule
- If you are able to become pregnant, you agree to use effective birth-control (barrier method) during treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving a stronger combination of TB drugs for meningitis can save more lives. It's for patients who have been diagnosed with tuberculosis meningitis and have not yet started more than 5 days of TB treatment.
This Phase 2 trial studies whether a TNF-blocking medicine can lower the risk of death in people with HIV who also have TB meningitis. You would receive standard TB meningitis treatment plus the study drug, if you meet the criteria.
This Phase 2 study tests whether a shorter, stronger 6-month set of medicines works as well as the usual 9-month regimen for tuberculous meningitis (TB infection in the covering of the brain/spinal cord). The goal is to improve outcomes while reducing treatment time and exposure.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This trial tests a shorter course of antibiotics for people with mild spinal tuberculosis. It aims to see if a shorter treatment works just as well as the standard longer course, which could mean fewer side effects and a quicker recovery.
This trial tests whether a shorter, rifampicin-based treatment works well for people with less severe TB in the lungs. If you have limited TB that is sensitive to rifampicin, you might be able to take medicine for a shorter time than usual.
Hear when a new Tuberculous Meningitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.